Reduction in Absolute Neutrophil Counts in Patient on Clozapine Infected with COVID-19

Reduction in Absolute Neutrophil Counts in Patient on Clozapine Infected with COVID-19

Despite its severe adverse effects, such as agranulocytosis, clozapine is the primary treatment for treatment-resistant schizophrenia. The established clozapine monitoring system has contributed to reducing agranulocytosis incidence and mortality rates. However, the pandemic coronavirus disease 2019...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fitri Fareez Ramli, Adli Ali, Syed Alhafiz Syed Hashim, Yusof Kamisah, Normala Ibrahim
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
clozapine
coronavirus
schizophrenia
Medicine
R
Acceso en línea:https://doaj.org/article/3c56692ef4534d3395caf38bd4a91c5e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares